Skip to content
2000
Volume 21, Issue 6
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

Dengue is the fastest-growing viral disease caused by an RNA virus, namely dengue virus, throughout India due to global warming. It has been declared a global threat by the World Health Organization due to the upsurge in cases as well as the deaths due to dengue over the last two decades. Most commonly, four serotypes of dengue viruses have high morbidity and mortality throughout the world. The major transmitting agents of this virus are the two species of the female mosquito, and . In West Bengal, several outbreaks were reported at different times. Dengue-infected persons were categorized into different categories based on their clinical symptoms. Being a viral disease, it is only managed based on the clinical symptoms, and no specific drugs are available for the treatment of dengue patients. The common methods of management are fluid management and nutritional management to balance the body’s fluid and strengthen the body’s immunity. Several micronutrients, like vitamins D, E, and C, play a major role in dengue management. Other than these vitamins, micronutrients, like zinc and iron, were also successfully used for dengue management. At present, the only way to manage dengue patients is through supportive therapy and micronutrient supplementation.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnf/10.2174/0115734013340202241108062720
2025-02-25
2025-10-26

  • From This Site

    /content/journals/cnf/10.2174/0115734013340202241108062720
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. HossainM.S. NomanA.A. MamunS.M.A.A. MosabbirA.A. Twenty-two years of dengue outbreaks in Bangladesh: Epidemiology, clinical spectrum, serotypes, and future disease risks.Trop. Med. Health20235113710.1186/s41182‑023‑00528‑6 37434247
     [Google Scholar]
  2. StanawayJ.D. ShepardD.S. UndurragaE.A. The global burden of dengue: An analysis from the global burden of disease study 2013.Lancet Infect. Dis.201616671272310.1016/S1473‑3099(16)00026‑8 26874619
     [Google Scholar]
  3. JagtapS. PattabiramanC. SankaradossA. KrishnaS. RoyR. Evolutionary dynamics of dengue virus in India.PLoS Pathog.2023194e101086210.1371/journal.ppat.1010862 37011104
     [Google Scholar]
  4. AfreenN. NaqviI.H. BroorS. AhmedA. ParveenS. Phylogenetic and molecular clock analysis of dengue serotype 1 and 3 from New Delhi, India.PLoS One20151011e014162810.1371/journal.pone.0141628 26536458
     [Google Scholar]
  5. ZalaDB KhanV KakadiyaM SanghaiAA DasVK Circulation of dengue serotypes in the Union territory of Dadra and Nagar Haveli Parasite Epidemiol Cont20181011e014162810.1016/j.parepi.2020.e00194
     [Google Scholar]
  6. Handbook for Clinical Management of Dengue. World Health Organization20121118
     [Google Scholar]
  7. SurasombatpattanaP. HamelR. PatramoolS. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.Infect. Genet. Evol.20111171664167310.1016/j.meegid.2011.06.009 21722754
     [Google Scholar]
  8. MessinaJ.P. BradyO.J. GoldingN. The current and future global distribution and population at risk of dengue.Nat. Microbiol.2019491508151510.1038/s41564‑019‑0476‑8 31182801
     [Google Scholar]
  9. BradyO.J. GethingP.W. BhattS. Refining the global spatial limits of dengue virus transmission by evidence-based consensus.PLoS Negl. Trop. Dis.201268e176010.1371/journal.pntd.0001760 22880140
     [Google Scholar]
  10. MurhekarM.V. KamarajP. KumarM.S. Burden of dengue infection in India, 2017: A cross-sectional population based serosurvey.Lancet Glob. Health201978e1065e107310.1016/S2214‑109X(19)30250‑5 31201130
     [Google Scholar]
  11. GaneshkumarP. MurhekarM.V. PoornimaV. Dengue infection in India: A systematic review and meta-analysis.PLoS Negl. Trop. Dis.2018127e000661810.1371/journal.pntd.0006618 30011275
     [Google Scholar]
  12. BanikG.B. PalT.K. MandalA. ChakrabortyM.S. ChakravartiS.K. Dengue hemorrhagic fever in Calcutta.Indian Pediatr.1994316685687 7896394
     [Google Scholar]
  13. GuptaE. DarL. KapoorG. BroorS. The changing epidemiology of dengue in Delhi, India.Virol. J.2006319210.1186/1743‑422X‑3‑92 17083743
     [Google Scholar]
  14. GuptaN. SrivastavaS. JainA. ChaturvediU.C. Dengue in India.Indian J. Med. Res.20121363373390 23041731
     [Google Scholar]
  15. MishraG. JainA. PrakashO. Molecular characterization of dengue viruses circulating during 2009-2012 in Uttar Pradesh, India.J. Med. Virol.2015871687510.1002/jmv.23981 24889214
     [Google Scholar]
  16. Dengue and severe dengue 2022. Available fromhttps://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
  17. BbD. HollaR. UnnikrishnanB. Clinical and seasonal pattern of dengue in a tertiary care hospital of South West India.F1000 Res.20231281710.12688/f1000research.126845.3 38623379
     [Google Scholar]
  18. Dengue Control Dengue/severe Dengue. WHO 2017. Available from:https://www.who.int/health-topics/dengue-and-severe-dengue#tab=tab_1
  19. Brathwaite DickO. San MartínJ.L. MontoyaR.H. del DiegoJ. ZambranoB. DayanG.H. The history of dengue outbreaks in the Americas.Am. J. Trop. Med. Hyg.201287458459310.4269/ajtmh.2012.11‑0770 23042846
     [Google Scholar]
  20. ChakravartiA. AroraR. LuxemburgerC. Fifty years of dengue in India.Trans. R. Soc. Trop. Med. Hyg.2012106527328210.1016/j.trstmh.2011.12.007 22357401
     [Google Scholar]
  21. MutheneniS.R. MorseA.P. CaminadeC. UpadhyayulaS.M. Dengue burden in India: recent trends and importance of climatic parameters.Emerg. Microbes Infect.201768e7010.1038/emi.2017.57
     [Google Scholar]
  22. Dengue cases rising in India: Everything you must know about common signs, precautions and treatment. 2022. Available from:https://economictimes.indiatimes.com/magazines/panache/denguecases-rising-in- india-everything-you-must-know-about-common-signs- precautionstreatment/articleshow/94471467.cms?from=mdr
  23. BanerjeeS. Importance of proper nutrition in dengue infections.J Nutr Metab Health Sci20225414014210.18231/j.ijnmhs.2022.026
     [Google Scholar]
  24. RoyS.K. GoswamiB.K. BhattacharjeeS. Genetic characterization of dengue virus from patients presenting multi-serotypic infections in the Northern West Bengal, India.Virus Genes2023591455410.1007/s11262‑022‑01950‑4
     [Google Scholar]
  25. MajhiJ. SinghR. YadavV. Dynamics of dengue outbreaks in gangetic West Bengal: A trend and time series analysis.J. Family Med. Prim. Care20209115622562810.4103/jfmpc.jfmpc_800_20
     [Google Scholar]
  26. BhattS. GethingP.W. BradyO.J. The global distribution and burden of dengue.Nature2013496744650450710.1038/nature12060 23563266
     [Google Scholar]
  27. World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New Ed. Geneva: WHO2009
     [Google Scholar]
  28. National Vector Borne Disease Control Programme (NVBDCP), Ministry of Health & Family Welfare, Government of India 2020 Designed and Developed by Center for Health Informatics. Accessed 22 Jan 2024. Available from:https://nvbdcp.gov.in/index4.php? lang=1&level=0&linkid=431&lid=3715
  29. AhmedS. FinkelsteinJ.L. StewartA.M. Micronutrients and Dengue.Am. J. Trop. Med. Hyg.20149151049105610.4269/ajtmh.14‑0142 25200269
     [Google Scholar]
  30. GublerD.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century.Trends Microbiol.200210210010310.1016/S0966‑842X(01)02288‑0 11827812
     [Google Scholar]
  31. VaughnD.W. GreenS. KalayanaroojS. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.J. Infect. Dis.200018112910.1086/315215 10608744
     [Google Scholar]
  32. RothmanA.L. Pathogenesis of dengue virus infection.2012Available fromwww.uptodate.com/contents/pathogenesis-of-dengue-virus-infection
     [Google Scholar]
  33. KuraneI. EnnisF.A. Production of interferon alpha by dengue virus-infected human monocytes.J. Gen. Virol.198869244544910.1099/0022‑1317‑69‑2‑445 3339332
     [Google Scholar]
  34. TayalA. KabraS.K. LodhaR. Management of dengue: An updated review.Indian J. Pediatr.202390216817710.1007/s12098‑022‑04394‑8 36574088
     [Google Scholar]
  35. Handbook for Clinical Management of Dengue. Geneva, Switzerland: WHO2012
  36. Palanichamy KalaM. St JohnA.L. RathoreA.P.S. Dengue: Update on clinically relevant therapeutic strategies and vaccines.Curr. Treat. Options Infect. Dis.2023152275210.1007/s40506‑023‑00263‑w 37124673
     [Google Scholar]
  37. RoufR. RabbaniR. RabbaniR. Dengue fever, expanded dengue syndrome and dengue shock syndrome: Clinical profile, management and outcome of patients at a tertiary hospital, Dhaka, Bangladesh.Bangladesh J Med2020312586310.3329/bjm.v31i2.48533
     [Google Scholar]
  38. WillsB.A. DungN.M. LoanH.T. Comparison of three fluid solutions for resuscitation in dengue shock syndrome.N. Engl. J. Med.2005353987788910.1056/NEJMoa044057 16135832
     [Google Scholar]
  39. DungN.M. DayN.P.J. TamD.T.H. Fluid replacement in dengue shock syndrome: A randomized, double-blind comparison of four intravenous-fluid regimens.Clin. Infect. Dis.199929478779410.1086/520435 10589889
     [Google Scholar]
  40. NhanN.T. PhuongC.X.T. KneenR. Acute management of dengue shock syndrome: A randomized double-blind comparison of 4 intravenous fluid regimens in the first hour.Clin. Infect. Dis.200132220421310.1086/318479 11170909
     [Google Scholar]
  41. RosenbergerK.D. LumL. AlexanderN. JunghanssT. WillsB. JaenischT. Vascular leakage in dengue – clinical spectrum and influence of parenteral fluid therapy.Trop. Med. Int. Health201621344545310.1111/tmi.12666 26752720
     [Google Scholar]
  42. KissoonN. RanjitS. RamanathanG. KissoonN. Targeted interventions in critically Ill children with severe dengue.Indian J. Crit. Care Med.201822315416110.4103/ijccm.IJCCM_413_17 29657372
     [Google Scholar]
  43. Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever. South-East AsiaWHO2011
     [Google Scholar]
  44. MasriM.F.B. MantriC.K. RathoreA.P.S. JohnA.L.S. Peripheral serotonin causes dengue virus–induced thrombocytopenia through 5HT2 receptors.Blood2019133212325233710.1182/blood‑2018‑08‑869156 30755421
     [Google Scholar]
  45. SunD.S. KingC.C. HuangH.S. Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice.J. Thromb. Haemost.20075112291229910.1111/j.1538‑7836.2007.02754.x 17958746
     [Google Scholar]
  46. RalapanawaU. AlawattegamaA.T.M. GunrathneM. TennakoonS. KularatneS.A.M. JayalathT. Value of peripheral blood count for dengue severity prediction.BMC Res. Notes201811140010.1186/s13104‑018‑3505‑4
     [Google Scholar]
  47. LamP.K. NgocT.V. Thu ThuyT.T. The value of daily platelet counts for predicting dengue shock syndrome: Results from a prospective observational study of 2301 Vietnamese children with dengue.PLoS Negl. Trop. Dis.2017114e000549810.1371/journal.pntd.0005498
     [Google Scholar]
  48. LyeD.C. ArchuletaS. Syed-OmarS.F. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: A multicentre, open-label, randomised, superiority trial.Lancet2017389100791611161810.1016/S0140‑6736(17)30269‑6 28283286
     [Google Scholar]
  49. AssirM.Z.K. KamranU. AhmadH.I. Effectiveness of platelet transfusion in dengue Fever: A randomized controlled trial.Transfus. Med. Hemother.201340536236810.1159/000354837 24273491
     [Google Scholar]
  50. LeeT.H. WongJ.G. LeoY.S. Potential harm of prophylactic platelet transfusion in adult dengue patients.PLoS Negl. Trop. Dis.2016103e000457610.1371/journal.pntd.0004576
     [Google Scholar]
  51. OjhaA. NandiD. BatraH. Platelet activation determines the severity of thrombocytopenia in dengue infection.Sci. Rep.201774169710.1038/srep41697
     [Google Scholar]
  52. WillsB.A. OraguiE.E. StephensA.C. Coagulation abnormalities in dengue hemorrhagic Fever: Serial investigations in 167 Vietnamese children with dengue shock syndrome.Clin. Infect. Dis.200235327728510.1086/341410 12115093
     [Google Scholar]
  53. SinglaM. KarM. SethiT. Immune response to dengue virus infection in pediatric patients in new Delhi, India-association of viremia, inflammatory mediators and monocytes with disease severity.PLoS Negl. Trop. Dis.2016104e000464210.1371/journal.pntd.0004642
     [Google Scholar]
  54. NguyenN.M. TranC.N.B. PhungL.K. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients.J. Infect. Dis.201320791442145010.1093/infdis/jis470 22807519
     [Google Scholar]
  55. TricouV. MinhN.N. VanT.P. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.PLoS Negl. Trop. Dis.20126610.1371/annotation/8683caec‑b309‑46d7‑bc47‑dc9cc27108e4
     [Google Scholar]
  56. WhitehornJ. NguyenC.V.V. KhanhL.P. Lovastatin for the treatment of adult patients with dengue: A randomized, double-blind, placebo-controlled trial.Clin. Infect. Dis.2015624civ94910.1093/cid/civ949 26565005
     [Google Scholar]
  57. LowJ.G. SungC. WijayaL. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): A phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.Lancet Infect. Dis.201414870671510.1016/S1473‑3099(14)70730‑3 24877997
     [Google Scholar]
  58. KeuschG.T. The history of nutrition: Malnutrition, infection and immunity.J. Nutr.20031331336S340S10.1093/jn/133.1.336S 12514322
     [Google Scholar]
  59. ChandraR.K. Nutrition and the immune system: An introduction.Am. J. Clin. Nutr.1997662460S463S10.1093/ajcn/66.2.460S 9250133
     [Google Scholar]
  60. EricksonK.L. MedinaE.A. HubbardN.E. Micronutrients and innate immunity.J. Infect. Dis.2000182s1Suppl. 1S5S1010.1086/315922 10944478
     [Google Scholar]
  61. BhaskaramP. Micronutrient malnutrition, infection, and immunity: An overview.Nutr. Rev.2002605 Pt 2Suppl. 5S40S4510.1301/00296640260130722 12035857
     [Google Scholar]
  62. GiraldoD.M. CardonaA. Urcuqui-InchimaS. High-dose of vitamin D supplement is associated with reduced susceptibility of monocyte-derived macrophages to dengue virus infection and pro-inflammatory cytokine production: An exploratory study.Clin. Chim. Acta201847814015110.1016/j.cca.2017.12.044 29289621
     [Google Scholar]
  63. RammohanS. BhandareB. VoggaK.M. The efficacy of vitamin C on hemoglobin levels and white blood cell count as an adjuvant in the treatment of dengue fever.World J. Pharm. Res.201981311041119
     [Google Scholar]
  64. ZamanS. MahmudM.R. KhalidM.A. Effectiveness of vitamin D in prevention of dengue haemorrhagic fever and dengue shock syndrome.J Rawalpindi Med Coll201721205207
     [Google Scholar]
  65. ChathuranganaP.W.P. SamaranayakeD.B.D.L. QuientersV.G. WickramasingheV.P. Effects of vitamin E supplementation on the clinical outcome of dengue fever and dengue haemorrhagic fever in children.Asian Pac. J. Trop. Dis.201771164564910.12980/apjtd.7.2017D7‑176
     [Google Scholar]
  66. Ali SyedA. Bin ZafarS. Ali ShahA. AwanS. The use of folic acid in dengue: Has it any value?Trop. Doct.2019492858710.1177/0049475519827110 30755107
     [Google Scholar]
  67. RerksuppapholS. RerksuppapholL. A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children.Int. J. Prev. Med.2018918810.4103/ijpvm.IJPVM_367_17 30450171
     [Google Scholar]
  68. MehtaS. FawziW. Effects of vitamins, including vitamin A, on HIV/AIDS patients.Vitam. Horm.20077535538310.1016/S0083‑6729(06)75013‑0 17368322
     [Google Scholar]
  69. GlasziouP.P. MackerrasD.E. Vitamin A supplementation in infectious diseases: A meta-analysis.BMJ1993306687436637010.1136/bmj.306.6874.366 8461682
     [Google Scholar]
  70. FawziW.W. MsamangaG.I. SpiegelmanD. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania.Lancet199835191141477148210.1016/S0140‑6736(98)04197‑X 9605804
     [Google Scholar]
  71. KlassenP. BiesalskiH.K. MazariegosM. SolomonsN.W. FürstP. Classic dengue fever affects levels of circulating antioxidants.Nutrition200420654254710.1016/j.nut.2004.03.016 15165617
     [Google Scholar]
  72. AlagarasuK. MemaneR.S. ShahP.S. Polymorphisms in the retinoic acid-1 like-receptor family of genes and their association with clinical outcome of dengue virus infection.Arch. Virol.201516061555156010.1007/s00705‑015‑2417‑z 25850761
     [Google Scholar]
  73. GrantW.B. GoldsteinM. MascitelliL. Ample evidence exists from human studies that vitamin D reduces the risk of selected bacterial and viral infections.Exp. Biol. Med. (Maywood)2010235121395139610.1258/ebm.2010.010c01 21171208
     [Google Scholar]
  74. Puerta-GuardoH. De la Cruz HernándezS.I. RosalesV.H. LudertJ.E. del AngelR.M. del AngelR.M. The 1α,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes.Antiviral Res.2012941576110.1016/j.antiviral.2012.02.006 22387385
     [Google Scholar]
  75. BhutiaS.K. Vitamin D in autophagy signaling for health and diseases: Insights on potential mechanisms and future perspectives.J. Nutr. Biochem.20229910884110.1016/j.jnutbio.2021.108841 34403722
     [Google Scholar]
  76. PadayattyS.J. KatzA. WangY. Vitamin C as an antioxidant: Evaluation of its role in disease prevention.J. Am. Coll. Nutr.2003221183510.1080/07315724.2003.10719272 12569111
     [Google Scholar]
  77. SchlueterA.K. JohnstonC.S. VitaminC. Overview and update.J. Evid. Based Complementary Altern. Med.2011161495710.1177/1533210110392951
     [Google Scholar]
  78. PadayattyS.J. SunA.Y. ChenQ. EspeyM.G. DriskoJ. LevineM. VitaminC. Intravenous use by complementary and alternative medicine practitioners and adverse effects.PLoS One201057e1141410.1371/journal.pone.0011414
     [Google Scholar]
  79. KothaiR. ChinchuE. ArulB. A retrospective study on the effect of vitamin C in the management of dengue fever in three different states of India.Int J Res Pharm Sci20191042670267310.26452/ijrps.v10i4.1525
     [Google Scholar]
  80. ShankarA.H. PrasadA.S. Zinc and immune function: The biological basis of altered resistance to infection.Am. J. Clin. Nutr.1998682Suppl.447S463S10.1093/ajcn/68.2.447S 9701160
     [Google Scholar]
  81. FerenčíkM. EbringerL. Modulatory effects of selenium and zinc on the immune system.Folia Microbiol. (Praha)200348341742610.1007/BF02931378 12879758
     [Google Scholar]
  82. KarM. KhanN.A. PanwarA. Zinc chelation specifically inhibits early stages of dengue virus replication by activation of NF-κB and induction of antiviral response in epithelial cells.Front. Immunol.201910234710.3389/fimmu.2019.02347 31632411
     [Google Scholar]
  83. FukadaT. KambeT. Molecular and genetic features of zinc transporters in physiology and pathogenesis.Metallomics20113766267410.1039/c1mt00011j 21566827
     [Google Scholar]
  84. BeharkaA. RedicanS. LekaL. MeydaniS.N. Vitamin E status and immune function. Methods Enzymol19972822476310.1016/S0076‑6879(97)82112‑X 9330293
     [Google Scholar]
  85. TanakaJ. FujiwaraH. TorisuM. Vitamin E and immune response. I. Enhancement of helper T cell activity by dietary supplementation of vitamin E in mice.Immunology1979384727734 316418
     [Google Scholar]
  86. GayR. MeydaniS.N. The effects of vitamin E, vitamin B6, and vitamin B12 on immune function.Nutr. Clin. Care20014418819810.1046/j.1523‑5408.2001.00142.x
     [Google Scholar]
  87. VaishA. VermaS. AgarwalA. GuptaL. GutchM. Effect of vitamin E on thrombocytopenia in dengue fever.Ann. Trop. Med. Public Health20125428228510.4103/1755‑6783.102004
     [Google Scholar]
  88. YamauchiR. VitaminE. Mechanism of its antioxidant activity.Food Sci. Technol. Int.19973430130910.3136/fsti9596t9798.3.301
     [Google Scholar]
  89. EkizC. AgaogluL. KarakasZ. GurelN. YalcinI. The effect of iron deficiency anemia on the function of the immune system.Hematol. J.20055757958310.1038/sj.thj.6200574 15692603
     [Google Scholar]
  90. ZhuY. TongL. NieK. Host serum iron modulates dengue virus acquisition by mosquitoes.Nat. Microbiol.20194122405241510.1038/s41564‑019‑0555‑x 31527795
     [Google Scholar]
  91. TsengCK LinCK WuYH Human heme oxygenase 1 is a potential host cell factor against dengue virus replication. Sci Rep 6: 32176.201610.1038/srep32176
     [Google Scholar]
/content/journals/cnf/10.2174/0115734013340202241108062720
Loading
Micronutrients and Dengue Fever: Exploring their Role in Effective Management Strategies
Curr. Nutr. Food Sci. 21, 702 (2025); https://doi.org/10.2174/0115734013340202241108062720
/content/journals/cnf/10.2174/0115734013340202241108062720
/content/journals/cnf/10.2174/0115734013340202241108062720
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Dengue; DENV; iron; micronutrient supplementation; vitamin; zinc

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test